31.10.2016 • News

Ube and Mitsubishi Plan Chinese Battery JV

(c) Predrag Novakovic/iStockphoto
(c) Predrag Novakovic/iStockphoto

Two Japanese companies, Ube Industries and Mitsubishi Chemical, have agreed to combine their electrolyte businesses in China in a 50:50 joint venture. The deal aimed at enhancing technology and improving costs will take effect from April 2017 if approved by state authorities in China and other relevant countries. Ube and Mitsubishi said they may later consider extending the business, which supplies the lithium-ion batteries market, to other countries.

Ube Industries manufactures electrolytes at its Sakai plant n Osaka Prefecture, Japan, and at a plant located in Zhangjiagang, Jiangsu Province, China. Annual production capacity totals 10,000 t/y in Japan and 5,000 t/y in China. Mitsubishi’s production facilities are located at Yokkaichi in Mie Prefecture, Japan, Stockton-on-Tees, UK,  Memphis, Tennessee, USA, and Changshu, Jiangsu, China. The company’s Japanese output runs to 13,500 t/y, with 10,000 t/y produced in the UK, US and China.

Driven by government subsidies, the market for lithium-ion batteries used in automobiles is growing rapidly in China, Demand for battery materials including electrolytes is also sharply increasing, amid an increasingly competitive market, the future joint venture partners said.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read